Filter
1414
Filtered Results: 1414
Text search:
respiratory
communicable
diseases
control
Featured
Recommendations
153
New Publications
383
Language
Document type
No document type
699
Studies & Reports
274
Guidelines
229
Strategic & Response Plan
74
Manuals
72
Situation Updates
18
Training Material
17
Fact sheets
17
Dashboards/Maps
6
Resource Platforms
3
Brochures
2
Infographics
2
Videos
1
Countries / Regions
Global
115
Kenya
62
India
56
South Africa
50
Western and Central Europe
37
Liberia
35
Ethiopia
33
Africa
33
Nigeria
30
Bangladesh
30
Uganda
29
Rwanda
29
Latin America and the Carribbean
29
Nepal
27
Philippines
25
Ghana
24
Myanmar / Burma
24
Sierra Leone
23
Zambia
21
Namibia
20
Malawi
18
Syria
16
Eastern Europe
16
Tanzania
14
Ukraine
13
Lesotho
13
South–East Asia Region
13
Indonesia
10
East and Southern Africa
10
West and Central Africa
10
Brazil
9
Cambodia
8
Mozambique
8
Western Pacific Region
8
Congo, Democratic Republic of
7
Zimbabwe
7
Pakistan
7
Eastern Europe and Central Asia
7
Asia
7
North America
7
Jordan
6
Germany
6
Thailand
6
Botswana
6
Haiti
5
Sudan
5
Colombia
5
Guinea
4
Burkina Faso
4
Iraq
4
Lebanon
4
Yemen
4
Moldova
4
Mali
3
Cameroon
3
Somalia
3
South Sudan
3
Afghanistan
3
Argentina
3
Middle East and North Africa
3
Paraguay
3
Venezuela
3
Palestine
3
Tajikistan
3
Iran
3
Senegal
2
USA
2
Saudi Arabia
2
Turkey
2
Egypt
2
China
2
Papua New Guinea
2
Central African Republic
2
Peru
2
El Salvador
2
Bolivia
2
Madagascar
2
Bhutan
2
Albania
2
Laos
2
Timor Leste/ East Timor
2
Russia
2
Bulgaria
2
Mauritius
2
Côte d’Ivoire / Ivory Coast
1
Morocco
1
Gambia
1
Benin
1
Eswatini/ Swaziland
1
North Macedonia
1
Hungary
1
Burundi
1
Greece
1
Libya
1
Angola
1
Mexico
1
Sri Lanka
1
Chile
1
Other region
1
Poland
1
Djibouti
1
Southern Africa
1
Qatar
1
Romania
1
Slovakia
1
Kyrgyzstan
1
Kazakhstan
1
Georgia
1
Maldives
1
Tunisia
1
Azerbaijan
1
Authors & Publishers
Publication Years
Category
Countries
650
Public Health
211
Clinical Guidelines
128
Key Resources
54
Women & Child Health
45
Capacity Building
15
Pharmacy & Technologies
14
Toolboxes
COVID-19
144
NCDs
129
TB
105
Rapid Response
70
Planetary Health
66
AMR
46
Global Health Education
40
Caregiver
39
Conflict
38
HIV
34
Mental Health
29
Ebola
28
Refugee
21
NTDs
19
Natural Hazards
15
Pharmacy
14
Disability
9
Polio
9
Health Financing Toolbox
8
Zika
7
Specific Hazards
6
Cholera
5
Typhoon
1
Childhood Respiratory Diseases & the Environment learning objectives
•To understand how the respiratory tract is affected by the environment
...
Noncommunicable diseases (NCDs) – chief among them, cardiovascular diseases (heart disease and stroke), cancer, diabetes and chronic respiratory ...
Noncommunicable diseases (NCDs) – chief among them, cardiovascular diseases (heart disease and stroke), cancer, diabetes and chronic respiratory ...
Diphtheria is caused by Corynebacterium species, mostly by toxin-producing Corynebacterium diphtheriae and rarely by toxin-producing strains of C. ulcerans and C. pseudotuberculosis. The most common type of diphtheria is classic respiratory diphther...
The document "Chronic Respiratory Diseases: A Handbook for Pharmacists" outlines the significant role pharmacists play in managing asthma and COPD, emphasizing patient education, disease prevention,...
The document is a policy brief by the NCD Alliance for the 2023 United Nations High-Level Meeting on Universal Health Coverage (UHC). It highlights the importance of integrating non-communicable diseases...
Background: Cardiovascular disease (CVD), mainly heart attack and stroke, is the
leading cause of premature mortality in low and middle income countries (LMICs).
Identifying and managing individuals at high risk of CVD is an important strategy to prevent and ... CVD, in addition to multisectoral population-based interventions to reduce CVD risk factors in the entire population.
Methods: We describe key public health considerations in identifying and managing individuals at high risk of CVD in LMICs.
Results: A main objective of any strategy to identify individuals at high CVD risk is to maximize the number of CVD events averted while minimizing the numbers of
individuals needing treatment. Scores estimating the total risk of CVD (e.g. ten-year risk of fatal and non-fatal CVD) are available for LMICs, and are based on the main CVD risk factors (history of CVD, age, sex, tobacco use, blood pressure, blood cholesterol and diabetes status). Opportunistic screening of CVD risk factors enables identification of persons with high CVD risk, but this strategy can be widely applied in low resource settings only if cost effective interventions are used (e.g. the WHO Package of Essential NCD interventions for primary health care in low resource settings package) and if treatment (generally for years) can be sustained, including continued availability ofaffordable medications and funding mechanisms that allow people to purchase medications without impoverishing them (e.g. universal access to health care). Thisalso emphasises the need to re-orient health systems in LMICs towards chronic diseases management.
Conclusion: The large burden of CVD in LMICs and the fact that persons with high
CVD can be identified and managed along cost-effective interventions mean that
health systems need to be structured in a way that encourages patient registration, opportunistic screening of CVD risk factors, efficient procedures for the management of chronic conditions (e.g. task sharing) and provision of affordable treatment for those with high CVD risk. The focus needs to be in primary care because that is where most of the population can access health care and because CVD programmes can be run effectively at this level.
Background
Low- and middle-income countries now experience the highest prevalence and mortality rates of cardiovascular disease.
Main text
While improving the availability and delivery of proven, effective therapies will no doubt mitigate this burden, we posit that studies evaluating cardiovasc...
This country cooperation strategy (CCS) outlines how the World Health Organization (WHO) will work with the Lao People’s Democratic Republic over the next five years (2024–2028), supporting the implementation of the five-year health sector development plans and the Health Sector Reform Strategy ...
Age-standardized estimates of current tobacco use, tobacco smoking and cigarette smoking (Tobacco control: Monitor)
The Public Health Burden of Commercial Tobacco Use
The burden of disease and death from commercial tobacco* use in the United States is
overwhelmingly caused by cigarettes and other combustible tobacco products.
The Incontrol video is a play put together by the ACACIA STUDY GROUP to address several misconceptions that people have about asthma.
The article "Barriers and determinants of asthma control in children and adolescents in Africa: a systematic review" analyzes factors contributing to poor asthma control in African youth. Based on s...
The Public Health Burden of Secondhand Exposure to Commercial Tobacco Smoke Secondhand smoke, the combination of smoke from burning commercial tobacco* products and the smoke breathed out by a person who is smoking, is deadly.
Occupational exposures to respirable crystalline silica occur in a variety of
industries and occupations because of its extremely common natural occurrence and the wide uses of materials and products that contain it. At least 1.7 million U.S. workers are potentially exposed to respirable crystallin...
Through technical consultations with countries and partners, WHO has led the development of Preparedness and Resilience for Emerging Threats Module 1: Planning for respiratory pathogen pandemics. Version 1.0. The Module, currently available as an ad...
The combined effects from ambient (outdoor) air pollution and indoor (household, in particular) air pollution cause approximately 7 million premature deaths every year, largely as a result of increased mortality from stroke, IHD, COPD, lung cancer and acute ... infections (1). Air pollution can occur in both the outdoor and indoor environments. Cook-stoves in homes, motor vehicles, industrial facilities and forest fires are common sources of air pollution. Air pollutants with the strongest evidence for adverse health outcomes include particulate matter (PM; both PM 2.5 (i.e. particles with an aerodynamic diameter
equal to or less than 2.5 μm) and PM10 (i.e. particles with an aerodynamic diameter equal to or less than 10 μm), ozone (O 3), nitrogen dioxide (NO 2 ), sulfur dioxide (SO 2 ) and carbon monoxide (CO). Air pollution is however composed of many more pollutants (1).
The ninth WHO report on the global tobacco epidemic tracks the progress made by countries in tobacco control since 2008 and, marks 15 years since the introduction of the MPOWER technical package which is designed to help countries implement the dema...
Reading Material for ASHA no.8
Risk assessment and priority interventions
